EGRP News Flash - March 5, 2010
Advance Notice Required for Large Budget Applications; Allowable Budget Levels for Competing Renewal Applications
This News Flash from NCI’s Epidemiology and Genetics Research Program (EGRP) contains two important items reminding investigators that:
- 8 Weeks Advance Notice is Required by our Division for Submission of Large-Budget Epidemiology Grant Applications
- Change in NCI Policy for Allowable Requested Budget Levels of Competing Continuation (Type 2) R01, U01 AND P01 Applications
8 Weeks Advance Notice Required by our Division for Submission of Large-budget Epidemiology Grant Applications
EGRP reminds current and prospective grantees that the National Cancer Institute (NCI) and the National Institutes of Health (NIH) require grant applications with requested budgets of $500,000 or more in direct costs in any one year to contact the appropriate program staff member and receive approval before submitting the proposals to NIH’s Center for Scientific Review (CSR). The NIH Guide for Grants and Contracts’ Notices NOT-CA-02-029 and NOT-OD-02-004 state that approval must be sought 6 weeks prior to submitting such applications. However, approval for applications assigned to our Division of Cancer Control and Population Sciences (DCCPS), of which EGRP is a part, must be sought at least 8 weeks prior to submission to CSR in order to complete the necessary internal processing.
Investigators must follow this policy, speak to the appropriate Program Director, and respond to requests for information. If advance notice of the proposed research and budget is not received and approval given by DCCPS, CSR will not accept the application, which will result in a delay in consideration until the next submission deadline. This policy applies to new, competing continuation, competing supplement, and amended/resubmitted applications. However, it does not apply to applications submitted in response to Requests for Applications (RFAs) or other funding opportunities with specified budget limits. Investigators should also be aware that an approval given to submit a large-budget application is limited to the cycle for which the proposal is being submitted.
Change in NCI Policy For Allowable Requested Budget Levels of Competing Renewal (Type 2) R01, U01, and P01 Applications
EGRP also reminds current and prospective grantees that in 2008 NCI changed its funding policy for all Type 2 applications (formerly called “competing continuation” applications) to cap first-year direct-costs so that they generally do not exceed an increase of 10% over the direct-costs awarded for the last year of the prior project period (i.e., the last Type 5 award). The change affects all Type 2 R01, U01, and P01 renewal applications regardless of the amount of the budget request or budget format (i.e., modular or non-modular). In certain situations, investigators may base calculations of permissible budget increases on the average direct costs for all years of the prior award. This average, increased by the 10% cap, then provides the nominal base for permissible costs in the first year of the renewal project. See the NIH Guide Notice, NOT-CA-08-026, for more information.
Access the NIH Guide for Grants and Contracts for details: